Pristinamycin: Old drug, new tricks?
Journal of Antimicrobial Chemotherapy, ISSN: 1460-2091, Vol: 69, Issue: 9, Page: 2319-2325
2014
- 27Citations
- 46Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations27
- Citation Indexes26
- 26
- CrossRef8
- Policy Citations1
- Policy Citation1
- Captures46
- Readers46
- 46
Article Description
Osteoarticular infections with Gram positive bacteria present an increasing challenge in an era of multidrugresistant organisms. Prolonged intravenous antibiotic treatment is often required, with associated risks, costs and difficulties with administration; a safe, effective oral option would be ideal for this indication. Pristinamycin, an oral streptogramin antibiotic with bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus, has been used for over 50 years in Europe for the treatment of osteoarticular infections. We review the published evidence for the treatment of native bone and prosthesisrelated osteoarticular infections with pristinamycin. © The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84905977681&origin=inward; http://dx.doi.org/10.1093/jac/dku167; http://www.ncbi.nlm.nih.gov/pubmed/24891428; https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/dku167; https://dx.doi.org/10.1093/jac/dku167; https://academic.oup.com/jac/article-abstract/69/9/2319/2911234?redirectedFrom=fulltext; https://academic.oup.com/jac/article/69/9/2319/2911234; https://academic.oup.com/jac/article-pdf/69/9/2319/9529048/dku167.pdf; http://jac.oxfordjournals.org/lookup/doi/10.1093/jac/dku167; http://jac.oxfordjournals.org/content/early/2014/06/02/jac.dku167; http://jac.oxfordjournals.org/cgi/doi/10.1093/jac/dku167; http://jac.oxfordjournals.org/content/early/2014/06/05/jac.dku167; http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dku167; https://academic.oup.com/jac; http://jac.oxfordjournals.org/content/69/9/2319
Oxford University Press (OUP)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know